IKT · ISSUER CIK 1750149
Inhibikase Therapeutics, Inc.
Between Jul 31, 2026 and Oct 28, 2026, 2 Inhibikase Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Jul 31, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 202616:32 | Jul 29, 2026 | IKT | 10% Owner · +3 joint | J · Other | — | −18,030,000 | 6,970,000 | -72% | — | ||
| Jul 31, 202616:05 | Jul 30, 2026 | IKT | Director | M · Exercise | $1.26 | +21,854 | 21,854 | New | $28K |